RxDoctor Payments Data

Jessica Hill

Physician Assistant · Okemos, MINPI 1902016181

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.1% of the total across 317 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,708, more than ten times the $73 reported in 2021. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,572in general payments, 2019–2025

Across 317 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Amgen$982
  • AbbVie$766
  • UCB, Inc.$537
  • Novartis$529
  • AstraZeneca$433
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$5,13292%
  • Education$4408%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,572 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept17$127,495
EnbrelEtanercept13$95,625
Cosentyx SyringeSecukinumab11$81,288
Hydroxychloroquine Sulfate116$6,442
MethotrexateMethotrexate Sodium124$3,035
Sulfasalazine61$1,882
Sulfasalazine DrSulfasalazine30$1,482
Prednisone133$1,374
Leflunomide12$556
Diclofenac Sodium16$504
Celecoxib31$463
Alendronate Sodium22$261
Meloxicam30$199

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEnbrel$982$95,62513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Okemos

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →